Phosphodiesterase
Products Related to Phosphodiesterase(34)
- GC48243Vardenafil-d5CAS: 1189685-70-8Purity: >99.00%
An internal standard for the quantification of vardenafil
- GC48469Moexipril-d5CAS: 1356929-49-1Purity: >99.00%
An internal standard for the quantification of moexipril
- GC48856Fenspiride-d5CAS: 1246911-67-0Purity: >99.00%
An internal standard for the quantification of fenspiride
- GC49683N-desethyl-N-methyl VardenafilCAS: 224785-87-9Purity: >95.00%
A potential impurity found in commercial preparations of vardenafil
- GC62215CRT0273750CAS: 1979939-16-6Purity: >98.50%
CRT0273750 es un inhibidor de la autotaxina (ATX) y modula los niveles de LPA en plasma (IC50 = 0,014 μM). CRT0273750 se puede utilizar en modelos de cÁncer dependientes de ATX/LPA.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC48243 | Vardenafil-d5 | 1189685-70-8 | >99.00% | |
An internal standard for the quantification of vardenafil | ||||
| GC48469 | Moexipril-d5 | 1356929-49-1 | >99.00% | |
An internal standard for the quantification of moexipril | ||||
| GC48856 | Fenspiride-d5 | 1246911-67-0 | >99.00% | |
An internal standard for the quantification of fenspiride | ||||
| GC48870 | Anagrelide-13C3 | - | >98.00% | |
| GC49079 | C82 | 691862-35-8 | >98.00% | |
An Mtb CdnP inhibitor | ||||
| GC49186 | O-Demethyl Apremilast | 1384441-38-6 | >95.00% | |
An active metabolite of apremilast | ||||
| GC49349 | O-Desethyl Sildenafil | 139755-91-2 | >95.00% | |
A metabolite of sildenafil | ||||
| GC49683 | N-desethyl-N-methyl Vardenafil | 224785-87-9 | >95.00% | |
A potential impurity found in commercial preparations of vardenafil | ||||
| GC60886 | GSK356278 | 720704-34-7 | >99.50% | |
GSK356278 es un inhibidor de la fosfodiesterasa 4 (PDE4) potente, selectivo, biodisponible por vÍa oral y que penetra en el cerebro, con pIC50 de 8,6, 8,8 y 8,7 para las PDE4A, PDE4B y PDE4D humanas, respectivamente. | ||||
| GC62215 | CRT0273750 | 1979939-16-6 | >98.50% | |
CRT0273750 es un inhibidor de la autotaxina (ATX) y modula los niveles de LPA en plasma (IC50 = 0,014 μM). CRT0273750 se puede utilizar en modelos de cÁncer dependientes de ATX/LPA. | ||||
